Maze Therapeutics, Inc.
Company Stats
- Market Cap
- $1.5B
- as of Sep 30, 2026
- Shares Outstanding
- 55.5M
- Free Float
- 77.8%
Income Statement
- Operating Income
- -$142.9M
- Net Income
- -$131.1M
- EBITDA
- -$140.5M
Cash Flow
- Free Cash Flow
- -$112.7M
- FCF Yield
- -7.5%
- Owner FCF Yield
- -8.6%
Balance Sheet
- Cash & Equivalents
- $189.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$112.7M | — |
| FY2024 | $167.5M | $74.8M | 44.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges